For over 130 years, Morishita Jintan has been a pioneer in preventive health solutions that combine traditional oriental medicine with innovative technology. It has developed its unique seamless capsule...
Shinnihonseiyaku, led by Takahiro Goto, navigates Japan's beauty landscape with simplicity and innovation. From adapting to demographic shifts to pioneering "Green Beauty", it shapes a...
Founded in 1893, Morishita Jintan has evolved into a multifaceted healthcare company renowned for its pioneering products and technologies. Celebrating its 130th anniversary, the company continues to...
SYNFOLIUM® is a surgical patch with knitted fabric consisting of both bio-absorbable and non-absorbable yarns, which are coated with cross-linked gelatin.
Muromachi Chemicals, a Japanese firm engaged in pharmaceuticals and environmental solutions, adapts to market changes by diversifying its offerings, all while striving for global health and environmental...
Muromachi Chemicals, a Japanese firm engaged in pharmaceuticals and environmental solutions, adapts to market changes by diversifying its offerings, all while striving for global health and environmental...
Umeken, a small yet pioneering Japanese company, has blended centuries-old traditional medicine techniques with modern innovation to create a global impact in both healthcare and skincare industries.
Japan's PhoenixBio leads pharmaceutical innovation with cutting-edge mice models boasting 90% human liver cells, helping redefine drug testing globally through a commitment to ethical practices.
In the fast-evolving landscape of pharmaceutical research and development, Japan-based company PhoenixBio is making waves with its groundbreaking contributions to the field. As a contract research organization...
KM Biologics plays a key role in safeguarding the health of Japan’s population, developing cutting-edge vaccines and blood-plasma products, and screening newborn babies.
Creator of the popular SOLinGEL patch, Dia Pharmaceutical is a pioneer in cosmetics technologies in Japan and is now targeting greater distribution in the U.S. marketplace.
